Full-Life Technologies
Clinical-stage radiotherapeutics company developing targeted cancer therapies with integrated isotope manufacturing
$150MSeries D+Debt
Role not disclosedH
HSG
Activity from announced rounds
Activity in this selectionOct 24, 2026 · Healthtech · Jan 1, 2026
HSG is the investment firm formerly known as Sequoia China, as identified in Clipto’s financing release. Full-Life also names it in its own announcement.
Recorded funding activity
The recorded activity includes Anew’s AI drug discovery, Clipto’s video-library tools and Math Magic’s generation of 3D models and physical products. Named HSG funds retain their separate identities.
Sources
- Rounds participated in
- 4
- Confirmed lead rounds
- — 4 roles undisclosed
- New companies
- 4 First participation on record · 0 follow-on
- Funding in participating rounds
- $378M 4 disclosed · full round size, not this investor’s share
By stage
By primary sector
By country
Rounds
4 in this selectionPulnovo Medical
Develops interventional therapies for pulmonary hypertension and heart failure
$100MStrategic
Role not disclosedVibrant Therapeutics
Develops intelligent, logic-gated therapeutics for solid tumors
$61MSeries A
Role not disclosedSpiro Medical
Develops a Pulmonary Neuromodulation System for asthma treatment
$67MSeries A
Role not disclosed